Intellia Therapeutics, Inc. (NTLA)
13.72
-0.13
(-0.94%)
USD |
NASDAQ |
May 07, 16:00
13.68
-0.04
(-0.29%)
After-Hours: 20:00
Intellia Therapeutics EPS Diluted (Quarterly) : -0.8263 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.222 |
| KalVista Pharmaceuticals, Inc. | -0.1055 |
| Beam Therapeutics, Inc. | 2.328 |
| Novavax, Inc. | -0.0581 |
| Tango Therapeutics, Inc. | -0.2945 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -95.79M |
| Revenue (Quarterly) | 23.02M |
| Total Expenses (Quarterly) | 118.80M |
| Enterprise Value | 1.280B |
| Gross Profit Margin (Quarterly) | 73.87% |
| Profit Margin (Quarterly) | -416.2% |
| Earnings Yield | -27.89% |
| Normalized Earnings Yield | -27.53 |